The New Way to Leverage KOLs in MedTech Marketing
For decades, healthcare innovators have leveraged partnerships with key opinion leaders (KOLs) to accelerate brand awareness and drive medtech sales. Conferences and trade shows served as the hub for new technology and groundbreaking innovations, with KOLs standing front and center promoting the latest and greatest products and services. This strategy was so effective that medtech […]
Launching Success: Optimizing Your Go-to-Market Strategy
For many, the path from development to commercialization is rife with hidden roadblocks and pitfalls at every turn. No matter how game-changing your solution is, it will never make it into the hands of clinicians without a robust go-to-market (GTM) strategy. Set your launch up for success by leveraging these five steps: Step 1 | […]
Breaking Down Digital Engagement Metrics for Healthcare Decision-Makers
Picture this: your medical device marketing team has spent weeks crafting perfectly worded messaging, beautifully designed graphics, and a fully optimized landing page with a fantastic user experience. You launch your campaign and wait patiently for the leads to start pouring in. Except…they don’t. What happened? Where did your efforts miss the mark? The unfortunate […]
Adapt Your Go-To-Market Strategy to Succeed Post-Pandemic
Healthcare business practices have evolved. Face-to-face interaction is no longer the leading sales tactic, and MedTech companies must adapt to the reality of unreachable decision-makers. With stagnant sales pipelines and restricted access to countless providers, healthcare innovators are scrambling to find new ways to generate leads. Digital Opens Doors Digital marketing paves the way for […]
Secrets to Getting Access to Decision Makers Like It’s 1999
MedTech companies are facing major roadblocks in generating demand for their new technologies. Gone are the days of catching doctors scrubbing in for surgery — and the endless sales opportunities that followed. In this new age of medtech sales, many are wondering if we will ever have the same access to decision-makers that we did […]